How do I buy IQVIA (IQV) stock?

Buying IQVIA (IQV) stock is now easy and instant through the Gotrade app. Download the Gotrade app from the App Store or Google Play. Create an account and verify your identity. Make a deposit. Search for the code "IQV", then tap "Trade". Tap the "Buy" button. Enter the amount you want to buy. You have two options: Buy IQV by number of shares. Buy fractional shares in dollars, starting from $1. Swipe up to confirm your order, and you're done!

How do I tell if IQV is expensive or cheap?

There's no single perfect answer, but common approaches include: Compare valuation (e.g., P/E, P/S) against historical averages or competitors. Review revenue and earnings growth. Check margins and cash flow. Evaluate business outlook and the company's position within its industry. You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

IQVIA (IQV) Stock

Q: What is the minimum investment for IQV on Gotrade?

On Gotrade , you don't have to buy a full share. With fractional shares, you can start investing in IQVIA from just $1. A small budget shouldn't stop you from building a US stock portfolio.

NASDAQ · IQV

Trade IQV

Key stats

Market cap: $45.24B
Price / Earnings ratio: 32.5x
EPS (TTM): $8.31
Volume: Loading
52-week high: $284.50
52-week low: $154.50
EPS vs analyst estimate: +4.9%Q3 FY25 · $3.00 vs $2.86

Source: third-party data provider, as of November 13, 2026

EPS estimate: analyst consensus

Compare with IQV

Technical indicators

RSI 14: 55.34
MACD 12/26/9: 2.02
EMA 9 of MACD: 1.71
MACD histogram: 0.31
SMA 50: $267.40; Price above SMA 50
EMA 50: $263.34; Price above EMA 50
SMA 200: $210.72; Price above SMA 200
EMA 200: $227.59; Price above EMA 200

Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.

Analyst ratings

Analyst consensus: Buy

Based on 11 analyst ratings

Strong Sell0

Sell0

Hold1

Buy10

Strong Buy0

Third-party analyst opinion, not a recommendation from Gotrade.

Financials

Performance

Revenue

Net income

Net margin %

2021

2022

2023

2024

2025

20B13B6B0

Debt & Balance Sheet

Total assets

Total liabilities

2021

2022

2023

2024

2025

36B24B12B0

Revenue to Profit

2025

$16.3B

Revenue

$0.0

Cost of revenue

$5.4B

Gross profit

$0.0

Operating expenses

$1.4B

Net income

Earnings

EPS forecast

Actual EPS

$3.00

$2.86

Q3FY25

$3.29

Q4FY25

$2.82

Q1FY26

$2.74

Q2FY26

$2.94

Q3FY26

The market is expecting earnings per share of $2.94 for this quarter. The company has not yet shared when it is announcing earnings.

Source: third-party data provider

About IQVIA

IQVIA is a leading global provider of advanced analytics, technology solutions and contract research services to the life sciences industry. Formed through the merger of IMS Health and Quintiles, IQVIA applies human data science — leveraging the analytic rigor and clarity of data science to the ever-expanding scope of human science — to enable companies to reimagine and develop new approaches to clinical development and commercialization, speed innovation and accelerate improvements in healthcare outcomes.

SectorHealthcare

IndustryDiagnostics & Research

Employees94,000

CEOMr. Ari Bousbib

IPO DateMay 9, 2013

HeadquartersDurham, NC

Key Executives

Name	Title	Year Born
Mr. Ari Bousbib	CEO & Chairman	1961
Mr. Michael J. Fedock MBA	Executive VP & Chief Financial Officer	1976
Mr. Eric M. Sherbet J.D.	Executive VP, General Counsel & Secretary	1964
Mr. W. Richard Staub III	President of Research & Development Solutions	1963
Mr. Alistair Grenfell	President of Commercial Solutions	1974
Mr. James G. Berkshire	Executive Vice President of Global Infrastructure & Operations	1974
Ms. Keriann Cherofsky	Senior VP, Corporate Controller & Chief Accounting Officer	1985
Dr. Jeffrey A. Spaeder M.D.	Chief Medical & Scientific Officer	—
Mr. Duane Sachs	Senior Vice President of Corporate Development	—
Ms. Trudy Stein	Chief Human Resources Officer & Executive VP	—

Seasonality

Monthly price change (%)

	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
2021											+2.9	+8.8
2022	-10.5	-6.9	+1.5	-9.3	-0.8	+3.3	+11.7	-10.8	-14.4	+12.6	+4.1	-7.1
2023	+12.5	-10.7	-5.6	-5.9	+3.6	+13.0	+1.2	+1.6	-12.3	-6.7	+18.9	+6.7
2024	-9.6	+17.0	+0.2	-6.9	-5.9	-2.3	+18.1	+1.3	-4.8	-11.0	-4.0	-2.6
2025	+3.2	-5.2	-4.6	-9.4	-7.1	+13.3	+14.3	+4.6	+3.4	+6.2	+7.5	-1.3
2026	+2.1	-22.7	-2.1	-8.1	+15.5	+3.4	+15.7	+11.9	+4.1	+2.5	+6.2

Stocks in the same sector

Labcorp Holdings Inc.

Thermo Fisher Scientific

FAQ

Buying IQVIA (IQV) stock is now easy and instant through the Gotrade app.

Download the Gotrade app from the App Store or Google Play.
Create an account and verify your identity.
Make a deposit.
Search for the code "IQV", then tap "Trade".
Tap the "Buy" button.
Enter the amount you want to buy. You have two options:
1. Buy IQV by number of shares.
2. Buy fractional shares in dollars, starting from $1.
Swipe up to confirm your order, and you're done!

On Gotrade, you don't have to buy a full share. With fractional shares, you can start investing in IQVIA from just $1. A small budget shouldn't stop you from building a US stock portfolio.

At the moment, IQVIA (IQV) does not pay dividends because it focuses on reinvesting profits for company growth (a growth stock). However, you can still potentially earn profit from share price increases (capital gains). Track IQV's performance via the price chart in the Gotrade app.

Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA).

You can place an order any time. It goes through when the US market (NYSE/NASDAQ) opens: 9:30 AM to 4:00 PM New York time, Monday to Friday. Pre-market and after-hours trading are open too.

The market is closed on US public holidays. The Gotrade app shows whether the market is open.

There's no single perfect answer, but common approaches include:

Compare valuation (e.g., P/E, P/S) against historical averages or competitors.
Review revenue and earnings growth.
Check margins and cash flow.
Evaluate business outlook and the company's position within its industry.

You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Trade Faster. Easier. Smarter.

#ReadyGoTrade

Welcome Reward up to $1,888

Create an account and trade US stocks on Gotrade

Download app

*Terms & conditions apply

IQVIA (IQV) Stock

Key stats

Compare with IQV

Recent news

Here's Why IQVIA Holdings (IQV) is a Strong Momentum Stock

Here's Why IQVIA Holdings (IQV) is a Strong Momentum Stock

What IQVIA (IQV) Said on Its Q3 Earnings Call

What IQVIA (IQV) Said on Its Q3 Earnings Call

IQVIA Holdings Q3 Earnings Beat Estimates, Revenues Increase 8% Y/Y

IQVIA Holdings Q3 Earnings Beat Estimates, Revenues Increase 8% Y/Y

IQVIA Holdings (IQV) Surpasses Q3 Earnings and Revenue Estimates

IQVIA Holdings (IQV) Surpasses Q3 Earnings and Revenue Estimates

Technical indicators

Analyst ratings

Financials

Performance

Debt & Balance Sheet

Revenue to Profit

Earnings

Latest news

Here's Why IQVIA Holdings (IQV) is a Strong Momentum Stock

Here's Why IQVIA Holdings (IQV) is a Strong Momentum Stock

What IQVIA (IQV) Said on Its Q3 Earnings Call

What IQVIA (IQV) Said on Its Q3 Earnings Call

IQVIA Holdings Q3 Earnings Beat Estimates, Revenues Increase 8% Y/Y

IQVIA Holdings Q3 Earnings Beat Estimates, Revenues Increase 8% Y/Y

IQVIA Holdings (IQV) Surpasses Q3 Earnings and Revenue Estimates

IQVIA Holdings (IQV) Surpasses Q3 Earnings and Revenue Estimates

IQVIA Reports Third-Quarter 2026 Results

IQVIA Reports Third-Quarter 2026 Results

IQVIA Gears Up to Post Q3 Earnings: Here's What Investors Should Know

IQVIA Gears Up to Post Q3 Earnings: Here's What Investors Should Know

IQVIA Holdings (IQV) Earnings Expected to Grow: Should You Buy?

IQVIA Holdings (IQV) Earnings Expected to Grow: Should You Buy?

IQVIA Selects Veeva Clinical Operations Applications

IQVIA Selects Veeva Clinical Operations Applications

Here's Why IQVIA Holdings (IQV) is a Strong Momentum Stock

Here's Why IQVIA Holdings (IQV) is a Strong Momentum Stock

IQVIA Launches IQVIA Life Science Models to Help Life Sciences Companies Predict Clinical Trial Outcomes

IQVIA Launches IQVIA Life Science Models to Help Life Sciences Companies Predict Clinical Trial Outcomes

About IQVIA

Key Executives

Fundamentals

Valuation

Profitability

Trading

Technical indicators

Analyst views

Seasonality

Compare stocks

Market cap

Price / Earnings ratio

Price / Sales ratio

Dividend yield

Average volume

Earnings per share

Stocks in the same sector

FAQ

Trade Faster. Easier. Smarter.

#ReadyGoTrade